Status:
ACTIVE_NOT_RECRUITING
Treatment for Speech and Language in Primary Progressive Aphasia
Lead Sponsor:
University of Texas at Austin
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
University of California, San Francisco
Conditions:
Primary Progressive Aphasia
Semantic Dementia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Primary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of speech and language networ...
Eligibility Criteria
Inclusion
- Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
- Score of 15 or higher on the Mini-Mental State Examination
Exclusion
- Other neurological or psychiatric diagnosis that may contribute to cognitive-linguistic deficits
- Significant, uncorrected visual or hearing impairment that would interfere with participation
- Score of less than 15 on the Mini-Mental State Examination
- Prominent initial non-speech-language impairment (cognitive, behavioral, motoric)
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04881617
Start Date
July 1 2017
End Date
December 30 2025
Last Update
November 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94158
2
University of Texas
Austin, Texas, United States, 78712